Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic)

MIT and Community Jameel, the social enterprise organization founded and chaired by Mohammed Abdul Latif Jameel, has launched the Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic). This is the fourth major collaborative effort between MIT and Community Jameel.

J-Clinic, a key part of the MIT Quest for Intelligence, will focus on developing machine learning technologies to revolutionize the prevention, detection, and treatment of disease. It will concentrate on creating and commercializing high-precision, affordable, and scalable machine learning technologies in areas of health care ranging from diagnostics to pharmaceuticals, with three main areas of focus:

(*) preventative medicine methods and technologies with the potential to change the course of noninfectious disease by stopping it in its tracks;
(*) cost-effective diagnostic tests that may be able to both detect and alleviate health problems; and
(*) drug discovery and development to enable faster and cheaper discovery, development, and manufacture of new pharmaceuticals, particularly those targeted for individually customized therapies.

J-Clinic’s holistic approach will utilize MIT’s strong expertise in cellular and medical biology, computer science, engineering, and the social sciences, among other areas.

The Abdul Latif Jameel Clinic for Machine Learning in Health at MIT aims to revolutionize disease prevention, detection, and treatment. The core mission is to incubate research at the intersection of computer science, big data, and the life sciences, and to drive the creation and commercialization of high-precision, affordable, and scalable machine-learning technologies to health care.

Regina Barzilay and James Collins have been named the faculty co-leads of the Abdul Latif Jameel Clinic for Machine Learning in Health, or J-Clinic. Institute Professor Philip Sharp will also serve as the chair of J-Clinic’s advisory board.

A key part of the MIT Quest for Intelligence, J-Clinic will focus on developing machine learning technologies to revolutionize the prevention, detection, and treatment of disease. It will concentrate on creating and commercializing high-precision, affordable, and scalable machine learning technologies in areas of health care ranging from diagnostics to pharmaceuticals.